Comparison of Vaccine Strategies Using Recombinant env–gag–pol MVA with or without an Oligomeric Env Protein Boost in the SHIV Rhesus Macaque Model

Overview of attention for article published in Virology, March 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 1 policy source

patent: 11 patents

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag…

Grant US-9453239-B2

United States of America

27 Sep 2016

Recombinant MVA viruses expressing modified env, gag and pol genes from HIV clade A/G…

Grant EP-1789438-B1

European Patent Office

15 Apr 2015

MVA expressing modified HIV envelope, gag, and pol genes

Grant US-8916172-B2

United States of America

23 Dec 2014

Compositions and methods for generating an immune response

Grant US-8623379-B2

United States of America

07 Jan 2014

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.